miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression

Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?

(2017) Rui Henrique et al.   EUROPEAN UROLOGY

The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4

(2017) Maria Sandbothe et al.   JOURNAL OF HEPATOLOGY

The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis

(2017) Shunbin Xiong et al.   JOURNAL OF PATHOLOGY

MDM4 is a rational target for treating breast cancers with mutant p53

(2017) Panimaya Jeffreena Miranda et al.   JOURNAL OF PATHOLOGY

miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer

(2017) Omer Faruk Karatas et al.   Oncotarget

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression

(2016) Cecilia Dallavalle et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-206 inhibits renal cell cancer growth by targeting GAK

(2016) Chao Wei et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene

(2016) Shuling Li et al.   ONCOLOGY REPORTS

miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1

(2016) FANGZHEN TIAN et al.   Oncology Letters

MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects

(2016) Chaoyi Xu et al.   Oncotarget

The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis

(2016) Junjie Bao et al.   Oncotarget

MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond

(2016) Jean-Christophe Marine et al.   Cold Spring Harbor Perspectives in Medicine

Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma

(2016) Yingqin Li et al.   PLoS Genetics

miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α

(2015) Jianda Zhou et al.   CANCER BIOLOGY & THERAPY

Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

(2015) Lei Cao et al.   CURRENT CANCER DRUG TARGETS

Renal Cell Carcinoma in Children, Adolescents and Young Adults: A National Cancer Database Study

(2015) Ardavan Akhavan et al.   JOURNAL OF UROLOGY

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer

(2015) Mulong Du et al.   Scientific Reports

MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1

(2015) Chuankai Zhang et al.   Protein & Cell

MDM4SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk

(2015) Liv B. Gansmo et al.   Cancer Medicine

miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome

(2013) Nadine Ratert et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy

(2012) Q. Li et al.   CLINICAL CANCER RESEARCH

The potential functions of primary microRNAs in target recognition and repression

(2010) Robin Deis Trujillo et al.   EMBO JOURNAL

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL